組織心臓弁:医療機器パイプライン分析

◆英語タイトル:Tissue Heart Valves - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDT20FB0171
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:128
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD12,000 ⇒換算¥1,320,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Tissue Heart Valves – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Tissue Heart Valves – Medical Devices Pipeline Assessment, 2019″ provides an overview of Tissue Heart Valves currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Tissue Heart Valves pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Tissue Heart Valves under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Tissue Heart Valves and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Tissue Heart Valves under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Tissue Heart Valves Overview 8
3 Products under Development 9
3.1 Tissue Heart Valves – Pipeline Products by Stage of Development 9
3.2 Tissue Heart Valves – Pipeline Products by Segment 10
3.3 Tissue Heart Valves – Pipeline Products by Territory 11
3.4 Tissue Heart Valves – Pipeline Products by Regulatory Path 12
3.5 Tissue Heart Valves – Pipeline Products by Estimated Approval Date 13
3.6 Tissue Heart Valves – Ongoing Clinical Trials 14
4 Tissue Heart Valves – Pipeline Products under Development by Companies 15
4.1 Tissue Heart Valves Companies – Pipeline Products by Stage of Development 15
4.2 Tissue Heart Valves – Pipeline Products by Stage of Development 16
5 Tissue Heart Valves Companies and Product Overview 18
5.1 Abbott Vascular Inc Company Overview 18
5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 Children’s Hospital Boston Company Overview 21
5.2.1 Children’s Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 21
5.3 Colibri Heart Valve LLC Company Overview 22
5.3.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview 22
5.4 CorMatrix Cardiovascular Inc Company Overview 24
5.4.1 CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview 24
5.5 CroiValve Ltd Company Overview 29
5.5.1 CroiValve Ltd Pipeline Products & Ongoing Clinical Trials Overview 29
5.6 CryoLife Inc Company Overview 30
5.6.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.7 Cytograft Tissue Engineering Inc (Inactive) Company Overview 32
5.7.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 32
5.8 Daidalos Solutions BV Company Overview 33
5.8.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 33
5.9 Edwards Lifesciences Corp Company Overview 36
5.9.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 36
5.10 Hancock Jaffe Laboratories Inc Company Overview 42
5.10.1 Hancock Jaffe Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 42
5.11 LivaNova PLC Company Overview 44
5.11.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 44
5.12 Medtronic plc Company Overview 49
5.12.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 49
5.13 Revivicor Inc Company Overview 51
5.13.1 Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 51
5.14 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 52
5.14.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 52
5.15 Stellenbosch University Company Overview 53
5.15.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 53
5.16 Tissue Regenix Ltd Company Overview 54
5.16.1 Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview 54
5.17 University of California Irvine Company Overview 56
5.17.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 56
5.18 University of Cambridge Company Overview 58
5.18.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 58
5.19 University of Minnesota Company Overview 59
5.19.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 59
5.20 University of Zurich Company Overview 60
5.20.1 University of Zurich Pipeline Products & Ongoing Clinical Trials Overview 60
5.21 Valcare Medical Company Overview 61
5.21.1 Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview 61
5.22 ValveXchange, Inc. (Inactive) Company Overview 62
5.22.1 ValveXchange, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62
5.23 VueKlar Cardiovascular Ltd (Inactive) Company Overview 65
5.23.1 VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 65
6 Tissue Heart Valves- Recent Developments 66
6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 66
6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 68
6.3 Oct 30, 2019: OmniGuide Holdings hires Giorgio Brusa as VP Global Marketing and Matthew Rice as Managing Director, OmniGuide Surgical Strategic Business Unit 69
6.4 Oct 30, 2019: LivaNova reports third quarter 2019 results 70
6.5 Oct 30, 2019: CryoLife reports third quarter 2019 financial results 71
7 Appendix 125
7.1 Methodology 125
7.2 About GlobalData 128
7.3 Contact Us 128
7.4 Disclaimer 128

List of Tables
Table 1: Tissue Heart Valves - Pipeline Products by Stage of Development
Table 2: Tissue Heart Valves - Pipeline Products by Segment
Table 3: Tissue Heart Valves - Pipeline Products by Territory
Table 4: Tissue Heart Valves - Pipeline Products by Regulatory Path
Table 5: Tissue Heart Valves - Pipeline Products by Estimated Approval Date
Table 6: Tissue Heart Valves - Ongoing Clinical Trials
Table 7: Tissue Heart Valves Companies - Pipeline Products by Stage of Development
Table 8: Tissue Heart Valves - Pipeline Products by Stage of Development
Table 9: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Status
Table 11: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Description
Table 12: Abbott Vascular Inc - Ongoing Clinical Trials Overview
Table 13: Tendyne Bioprosthetic Mitral Valve Implantation System - Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
Table 14: Tendyne Bioprosthetic Mitral Valve Implantation System - Expanded Clinical Study of the Tendyne Mitral Valve System
Table 15: Tendyne Bioprosthetic Mitral Valve Implantation System - Feasibility Study of the Tendyne Mitral Valve System for Use in Subjects with Mitral Annular Calcification
Table 16: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Heart Valve Leaflet - Product Status
Table 18: Heart Valve Leaflet - Product Description
Table 19: Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Pulmonary Valve - Product Status
Table 21: Pulmonary Valve - Product Description
Table 22: Sutureless Surgical Aortic Valve - Product Status
Table 23: Sutureless Surgical Aortic Valve - Product Description
Table 24: CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: CorMatrix Cor TRICUSPID ECM Valve Device - Product Status
Table 26: CorMatrix Cor TRICUSPID ECM Valve Device - Product Description
Table 27: CorMatrix ECM - Heart Valve Repair - Product Status
Table 28: CorMatrix ECM - Heart Valve Repair - Product Description
Table 29: CorMatrix ECM - Heart Valve Replacement - Product Status
Table 30: CorMatrix ECM - Heart Valve Replacement - Product Description
Table 31: Regenerating Tubular Mitral Valve - Product Status
Table 32: Regenerating Tubular Mitral Valve - Product Description
Table 33: CorMatrix Cardiovascular Inc - Ongoing Clinical Trials Overview
Table 34: CorMatrix Cor TRICUSPID ECM Valve Device - CorMatrix Cor TRICUSPID ECM Valve Replacement Safety and Early Feasibility
Table 35: CroiValve Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Tricuspid Valve Replacement Device - Product Status
Table 37: Tricuspid Valve Replacement Device - Product Description
Table 38: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: CryoValve SGAV - Product Status
Table 40: CryoValve SGAV - Product Description
Table 41: Synergraft Xenograft Heart Valve - Product Status
Table 42: Synergraft Xenograft Heart Valve - Product Description
Table 43: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Cytograft Valve - Product Status
Table 45: Cytograft Valve - Product Description
Table 46: Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Sutureless Aortic Valve Prosthesis - Product Status
Table 48: Sutureless Aortic Valve Prosthesis - Product Description
Table 49: Sutureless Mitral Valve Prostheses - Product Status
Table 50: Sutureless Mitral Valve Prostheses - Product Description
Table 51: Sutureless Tricuspid Valve Prostheses - Product Status
Table 52: Sutureless Tricuspid Valve Prostheses - Product Description
Table 53: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 54: GLX Aortic Conduit - Product Status
Table 55: GLX Aortic Conduit - Product Description
Table 56: INTUITY Valve System - Product Status
Table 57: INTUITY Valve System - Product Description
Table 58: Konect AVC - Product Status
Table 59: Konect AVC - Product Description
Table 60: Magna EASE Surgical Valve With GLX - Product Status
Table 61: Magna EASE Surgical Valve With GLX - Product Description
Table 62: Edwards Lifesciences Corp - Ongoing Clinical Trials Overview
Table 63: INTUITY Valve System - Impact of SAVR and TAVR on Patient's Activity and Mobility CAPABILITY Study
Table 64: INTUITY Valve System - Multi-center Experience with the Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement
Table 65: INTUITY Valve System - Surgical Treatment of Aortic Stenosis with a Next Generation Surgical Aortic Valve
Table 66: Magna EASE Surgical Valve With GLX - Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese Patients
Table 67: Magna EASE Surgical Valve With GLX - Prospective, Non-randomized, Multicenter Clinical Evaluation of the Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000a and 11000m) with a New Tissue Treatment Platform: COMMENCE

List of Figures
Figure 1: Tissue Heart Valves - Pipeline Products by Stage of Development
Figure 2: Tissue Heart Valves - Pipeline Products by Segment
Figure 3: Tissue Heart Valves - Pipeline Products by Territory
Figure 4: Tissue Heart Valves - Pipeline Products by Regulatory Path
Figure 5: Tissue Heart Valves - Pipeline Products by Estimated Approval Date
Figure 6: Tissue Heart Valves - Ongoing Clinical Trials

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[組織心臓弁:医療機器パイプライン分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆